FoxO3 reverses 5-fluorouracil resistance in human colorectal cancer cells by inhibiting the Nrf2/TR1 signaling pathway
Chao Liu(Shanghai University of Traditional Chinese Medicine), Qianming Du(First Affiliated Hospital of Zhengzhou University), Xiuting Liu(Washington University in St. Louis), Yan Zhao(China Pharmaceutical University), Jianjun Zou(Jiangsu Hengrui Medicine (China)), Sishi Peng(China Pharmaceutical University), Shuli Zhao(China Pharmaceutical University), Qiong‐Yu Mi(Nanjing Medical University), Bangshun He(Nanjing Medical University), Jianing Wang(Hong Kong Baptist University), Xu Zhang(Chinese Center For Disease Control and Prevention), Yan Yang(Anhui Medical University), Yan Zhang(Wuhan University), Zhaoying Yao(China Pharmaceutical University), Yubing Zhu(Capital Medical University), Xinliang Qu(Nanjing Medical University)
Cited by 67
Related Papers
RETRACTED ARTICLE: CircHIPK3 promotes colorectal cancer growth and metastasis by sponging miR-7
|Cell Death and Disease|2018|715
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|504
The pro-metastasis effect of circANKS1B in breast cancer
|Molecular Cancer|2018|347